http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 22 Jul 2024 08:31:30 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/HOOKIPA+Pharma+Inc.+%28HOOK%29+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486628.html <p>HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. Malte Peters as Chief Executive Officer and Terry Coelho as Executive Vice President and Chief Financial Officer, effective July 22, 2024. They will both retain their positions on the Board of Directors (“Board”).</p><p> </p><p>They succeed Jörn Aldag and Reinhard Kandera as CEO and CFO, respectively, who will be leaving the Company and stepping down from the Board.</p><p>Dr. Peters and Ms. Coelho, in close collaboration with the Board, will lead a http://www.streetinsider.com/Corporate+News/HOOKIPA+Pharma+Inc.+%28HOOK%29+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486628.html Mon, 22 Jul 2024 08:31:30 -0400 ARVN GMDA HOOK http://www.streetinsider.com/Corporate+News/HOOKIPA+Pharma+Inc.+%28HOOK%29+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486628.html <p>HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. Malte Peters as Chief Executive Officer and Terry Coelho as Executive Vice President and Chief Financial Officer, effective July 22, 2024. They will both retain their positions on the Board of Directors (“Board”).</p><p> </p><p>They succeed Jörn Aldag and Reinhard Kandera as CEO and CFO, respectively, who will be leaving the Company and stepping down from the Board.</p><p>Dr. Peters and Ms. Coelho, in close collaboration with the Board, will lead a http://www.streetinsider.com/Corporate+News/HOOKIPA+Pharma+Inc.+%28HOOK%29+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486628.html Mon, 22 Jul 2024 08:31:30 -0400 ARVN GMDA HOOK http://www.streetinsider.com/Corporate+News/HOOKIPA+Pharma+Inc.+%28HOOK%29+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486628.html <p>HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. Malte Peters as Chief Executive Officer and Terry Coelho as Executive Vice President and Chief Financial Officer, effective July 22, 2024. They will both retain their positions on the Board of Directors (“Board”).</p><p> </p><p>They succeed Jörn Aldag and Reinhard Kandera as CEO and CFO, respectively, who will be leaving the Company and stepping down from the Board.</p><p>Dr. Peters and Ms. Coelho, in close collaboration with the Board, will lead a http://www.streetinsider.com/Corporate+News/HOOKIPA+Pharma+Inc.+%28HOOK%29+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486628.html Mon, 22 Jul 2024 08:31:30 -0400 ARVN GMDA HOOK http://www.streetinsider.com/Management+Changes/HOOKIPA+Pharma+Inc.+%28HOOK%29+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486628.html <p>HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. Malte Peters as Chief Executive Officer and Terry Coelho as Executive Vice President and Chief Financial Officer, effective July 22, 2024. They will both retain their positions on the Board of Directors (“Board”).</p><p> </p><p>They succeed Jörn Aldag and Reinhard Kandera as CEO and CFO, respectively, who will be leaving the Company and stepping down from the Board.</p><p>Dr. Peters and Ms. Coelho, in close collaboration with the Board, will lead a http://www.streetinsider.com/Management+Changes/HOOKIPA+Pharma+Inc.+%28HOOK%29+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486628.html Mon, 22 Jul 2024 08:31:30 -0400 ARVN GMDA HOOK http://www.streetinsider.com/Management+Changes/HOOKIPA+Pharma+Inc.+%28HOOK%29+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486628.html <p>HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. Malte Peters as Chief Executive Officer and Terry Coelho as Executive Vice President and Chief Financial Officer, effective July 22, 2024. They will both retain their positions on the Board of Directors (“Board”).</p><p> </p><p>They succeed Jörn Aldag and Reinhard Kandera as CEO and CFO, respectively, who will be leaving the Company and stepping down from the Board.</p><p>Dr. Peters and Ms. Coelho, in close collaboration with the Board, will lead a http://www.streetinsider.com/Management+Changes/HOOKIPA+Pharma+Inc.+%28HOOK%29+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486628.html Mon, 22 Jul 2024 08:31:30 -0400 ARVN GMDA HOOK http://www.streetinsider.com/Management+Changes/HOOKIPA+Pharma+Inc.+%28HOOK%29+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486628.html <p>HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. Malte Peters as Chief Executive Officer and Terry Coelho as Executive Vice President and Chief Financial Officer, effective July 22, 2024. They will both retain their positions on the Board of Directors (“Board”).</p><p> </p><p>They succeed Jörn Aldag and Reinhard Kandera as CEO and CFO, respectively, who will be leaving the Company and stepping down from the Board.</p><p>Dr. Peters and Ms. Coelho, in close collaboration with the Board, will lead a http://www.streetinsider.com/Management+Changes/HOOKIPA+Pharma+Inc.+%28HOOK%29+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486628.html Mon, 22 Jul 2024 08:31:30 -0400 ARVN GMDA HOOK http://www.streetinsider.com/Press+Releases/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html <ul type="disc"><li style="margin-bottom:8pt;">Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial Officer</li><li style="margin-bottom:8pt;">Company is conducting a review of its business operations and strategy to determine best path to create shareholder value and realize the full potential of HB-200</li><li style="margin-bottom:8pt;">Sean Cassidy appointed to the Board of Directors<br /></li></ul> <p>NEW YORK and VIENNA, July 22, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. http://www.streetinsider.com/Press+Releases/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html Mon, 22 Jul 2024 08:30:00 -0400 ARVN ARVN GMDA HOOK HOOK http://www.streetinsider.com/Press+Releases/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html <ul type="disc"><li style="margin-bottom:8pt;">Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial Officer</li><li style="margin-bottom:8pt;">Company is conducting a review of its business operations and strategy to determine best path to create shareholder value and realize the full potential of HB-200</li><li style="margin-bottom:8pt;">Sean Cassidy appointed to the Board of Directors<br /></li></ul> <p>NEW YORK and VIENNA, July 22, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. http://www.streetinsider.com/Press+Releases/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html Mon, 22 Jul 2024 08:30:00 -0400 ARVN ARVN GMDA HOOK HOOK http://www.streetinsider.com/Press+Releases/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html <ul type="disc"><li style="margin-bottom:8pt;">Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial Officer</li><li style="margin-bottom:8pt;">Company is conducting a review of its business operations and strategy to determine best path to create shareholder value and realize the full potential of HB-200</li><li style="margin-bottom:8pt;">Sean Cassidy appointed to the Board of Directors<br /></li></ul> <p>NEW YORK and VIENNA, July 22, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. http://www.streetinsider.com/Press+Releases/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html Mon, 22 Jul 2024 08:30:00 -0400 ARVN ARVN GMDA HOOK HOOK http://www.streetinsider.com/Press+Releases/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html <ul type="disc"><li style="margin-bottom:8pt;">Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial Officer</li><li style="margin-bottom:8pt;">Company is conducting a review of its business operations and strategy to determine best path to create shareholder value and realize the full potential of HB-200</li><li style="margin-bottom:8pt;">Sean Cassidy appointed to the Board of Directors<br /></li></ul> <p>NEW YORK and VIENNA, July 22, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. http://www.streetinsider.com/Press+Releases/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html Mon, 22 Jul 2024 08:30:00 -0400 ARVN ARVN GMDA HOOK HOOK http://www.streetinsider.com/Press+Releases/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html <ul type="disc"><li style="margin-bottom:8pt;">Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial Officer</li><li style="margin-bottom:8pt;">Company is conducting a review of its business operations and strategy to determine best path to create shareholder value and realize the full potential of HB-200</li><li style="margin-bottom:8pt;">Sean Cassidy appointed to the Board of Directors<br /></li></ul> <p>NEW YORK and VIENNA, July 22, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. http://www.streetinsider.com/Press+Releases/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html Mon, 22 Jul 2024 08:30:00 -0400 ARVN ARVN GMDA HOOK HOOK http://www.streetinsider.com/Globe+Newswire/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html <ul type="disc"><li style="margin-bottom:8pt;">Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial Officer</li><li style="margin-bottom:8pt;">Company is conducting a review of its business operations and strategy to determine best path to create shareholder value and realize the full potential of HB-200</li><li style="margin-bottom:8pt;">Sean Cassidy appointed to the Board of Directors<br /></li></ul> <p>NEW YORK and VIENNA, July 22, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. http://www.streetinsider.com/Globe+Newswire/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html Mon, 22 Jul 2024 08:30:00 -0400 ARVN ARVN GMDA HOOK HOOK http://www.streetinsider.com/Globe+Newswire/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html <ul type="disc"><li style="margin-bottom:8pt;">Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial Officer</li><li style="margin-bottom:8pt;">Company is conducting a review of its business operations and strategy to determine best path to create shareholder value and realize the full potential of HB-200</li><li style="margin-bottom:8pt;">Sean Cassidy appointed to the Board of Directors<br /></li></ul> <p>NEW YORK and VIENNA, July 22, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. http://www.streetinsider.com/Globe+Newswire/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html Mon, 22 Jul 2024 08:30:00 -0400 ARVN ARVN GMDA HOOK HOOK http://www.streetinsider.com/Globe+Newswire/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html <ul type="disc"><li style="margin-bottom:8pt;">Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial Officer</li><li style="margin-bottom:8pt;">Company is conducting a review of its business operations and strategy to determine best path to create shareholder value and realize the full potential of HB-200</li><li style="margin-bottom:8pt;">Sean Cassidy appointed to the Board of Directors<br /></li></ul> <p>NEW YORK and VIENNA, July 22, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. http://www.streetinsider.com/Globe+Newswire/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html Mon, 22 Jul 2024 08:30:00 -0400 ARVN ARVN GMDA HOOK HOOK http://www.streetinsider.com/Globe+Newswire/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html <ul type="disc"><li style="margin-bottom:8pt;">Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial Officer</li><li style="margin-bottom:8pt;">Company is conducting a review of its business operations and strategy to determine best path to create shareholder value and realize the full potential of HB-200</li><li style="margin-bottom:8pt;">Sean Cassidy appointed to the Board of Directors<br /></li></ul> <p>NEW YORK and VIENNA, July 22, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. http://www.streetinsider.com/Globe+Newswire/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html Mon, 22 Jul 2024 08:30:00 -0400 ARVN ARVN GMDA HOOK HOOK http://www.streetinsider.com/Globe+Newswire/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html <ul type="disc"><li style="margin-bottom:8pt;">Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial Officer</li><li style="margin-bottom:8pt;">Company is conducting a review of its business operations and strategy to determine best path to create shareholder value and realize the full potential of HB-200</li><li style="margin-bottom:8pt;">Sean Cassidy appointed to the Board of Directors<br /></li></ul> <p>NEW YORK and VIENNA, July 22, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. http://www.streetinsider.com/Globe+Newswire/HOOKIPA+Pharma+Announces+Leadership+Changes+to+Intensify+Focus+on+HB-200/23486583.html Mon, 22 Jul 2024 08:30:00 -0400 ARVN ARVN GMDA HOOK HOOK